What does CUSIP 85858C107 represent in this 13F holders report?

CUSIP 85858C107 is the security identifier for STML - STEMLINE THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held STML - STEMLINE THERAPEUTICS INC - COM in Q1 2017?

73 institutional investors reported STML - STEMLINE THERAPEUTICS INC - COM for Q1 2017. Use the holders table for investor-level position and value details.

STEMLINE THERAPEUTICS INC - COM (STML)

CUSIP: 85858C107

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class: Equity / COM
Total 13F shares: 13,902,927
Share change: +5,164,292
Total reported value: $118,853,731
Put/Call ratio: 93%
Price per share: $8.55
Number of holders: 73
Value change: +$42,454,807
Number of buys: 50
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 85858C107?
CUSIP 85858C107 identifies STML - STEMLINE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2017
Previous quarter: Q4 2016

Recent filing periods for CUSIP 85858C107:

Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018

Institutional Holders of STEMLINE THERAPEUTICS INC - COM (STML) as of Q1 2017

As of 31 Mar 2017, STEMLINE THERAPEUTICS INC - COM (STML) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,902,927 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, AXA, MILLENNIUM MANAGEMENT LLC, and INTERNATIONAL BIOTECHNOLOGY TRUST PLC. This page lists 73 institutional shareholders reporting positions in this security for the Q1 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.